CRON

Cronos Group

2.00 USD
-0.01
0.50%
Updated Jul 30, 3:33 PM EDT
1 day
-0.50%
5 days
-3.85%
1 month
4.71%
3 months
6.38%
6 months
3.63%
Year to date
-2.91%
1 year
-17.70%
5 years
-69.92%
10 years
-73.75%
 

About: Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Employees: 459

0
Funds holding %
of 7,323 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

46% more call options, than puts

Call options by funds: $5.58M | Put options by funds: $3.81M

0.2% more ownership

Funds ownership: 11.35% [Q4 2024] → 11.55% (+0.2%) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

6% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 36

9% less capital invested

Capital invested by funds: $87.6M [Q4 2024] → $80M (-$7.61M) [Q1 2025]

11% less funds holding

Funds holding: 184 [Q4 2024] → 164 (-20) [Q1 2025]

48% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 31

Research analyst outlook

We haven’t received any recent analyst ratings for CRON.

Financial journalist opinion

Based on 8 articles about CRON published over the past 30 days

Neutral
GlobeNewsWire
5 days ago
Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 second quarter earnings conference call on Thursday, August 7, 2025 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.
Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025
Positive
MarijuanaStocks
1 week ago
Top Canadian Cannabis Picks for U.S. Market Expansion in 2025
As cannabis markets shift this week, Canadian cannabis stocks are once again gaining investor attention. At the same time, the U.S. industry continues to grow rapidly. In 2024, legal cannabis sales in the U.S. reached nearly $39 billion. Projections suggest that the number could climb past $44 billion in 2025. Growth is expected to continue at a strong pace through the decade. Despite this momentum, federal legalization remains stalled. However, several U.S. states are pushing forward with their own reform efforts. This steady progress at the state level continues to attract interest. Canadian companies with U.S. exposure stand to benefit from this evolving landscape. As a result, watching top-performing Canadian cannabis stocks this week could reveal key breakout opportunities.
Top Canadian Cannabis Picks for U.S. Market Expansion in 2025
Neutral
PRNewsWire
1 week ago
High Tide Closes on $30 Million Convertible Debt from Cronos Group Inc.
CALGARY, AB, and TORONTO, ON , July 16, 2025 /PRNewswire/ - High Tide Inc. ("High Tide") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it has closed a loan agreement (the "Loan Agreement") with a wholly owned subsidiary of Cronos Group Inc. (Nasdaq: CRON) (TSX: CRON) to secure convertible debt with a principal amount of $30 million (the "Junior Secured Loan"). High Tide intends to use this working capital to fund future acquisitions and organic growth as it seeks to expand its business and grow its domestic store network beyond 300 locations in Canada.
High Tide Closes on $30 Million Convertible Debt from Cronos Group Inc.
Positive
MarijuanaStocks
2 weeks ago
3 Top Canadian Marijuana Stocks To Watch As The Sector Looks To Bounce
2025 has been a troubled time for marijuana stock investors. With a lack of momentum and no sign of any upward trading, what are shareholders to do? Now, the cannabis industry outside of the public sector has been doing phenomenally. Some cannabis companies continue to grow and become even bigger and profitable. At this time, the legal market still faces an uphill climb, but as long as companies can fulfill the increase in consumer demand there is a light at the end of the tunnel.
3 Top Canadian Marijuana Stocks To Watch As The Sector Looks To Bounce
Positive
MarijuanaStocks
2 weeks ago
3 Marijuana Stocks To Watch: Key Trends Driving Cannabis Industry Growth
3 Marijuana Stocks To Watch: Key Trends Driving Cannabis Industry Growth
Positive
Seeking Alpha
3 weeks ago
Americans Should Buy Canadian Cannabis Companies
Canadian LPs offer compelling risk/reward versus U.S. cannabis stocks, with stronger balance sheets, tangible book value, and global opportunities due to federal legality. Despite recent rallies, Canadian LPs remain cheap on enterprise value to EBITDA, especially Village Farms, Organigram, and Tilray Brands, which I hold in my model portfolio. U.S. MSOs face significant risks from 280E tax liabilities and negative tangible equity, making Canadian LPs a safer bet for cannabis investors right now.
Americans Should Buy Canadian Cannabis Companies
Positive
Zacks Investment Research
3 weeks ago
New Strong Buy Stocks for July 3rd
CRON, CDE, SOUHY, PRM and STNG have been added to the Zacks Rank #1 (Strong Buy) List on July 3, 2025.
New Strong Buy Stocks for July 3rd
Neutral
GlobeNewsWire
4 weeks ago
Cronos Grows its International Footprint in Switzerland
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the supply and distribution of medical cannabis and healthcare training.
Cronos Grows its International Footprint in Switzerland
Neutral
GlobeNewsWire
1 month ago
Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding.
Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
Neutral
MarijuanaStocks
1 month ago
3 Cannabis Stocks For Investors To Secure For Future Gains
The current state of the cannabis sector has people feeling a type of way. To be more descriptive, those who are invested in marijuana stocks are feeling the backlash of the market. For some time, there has been a sharp decline in the overall trading for most top marijuana stocks. Now, you would think that with the sector down and showing no true signs of recovery, all is lost. That is not the case, as most companies are making money and having a positive impact.
3 Cannabis Stocks For Investors To Secure For Future Gains
Charts implemented using Lightweight Charts™